Skip to content

biote Corp.

BTMD

CIK 0001819253 · Medicinal Chemicals & Botanical Products · Nasdaq

  • Haymaker Acquisition Corp. III (until 2022-05-25)
← back to feed
Revenue (TTM)
$190.75M
−2.5% YoY Q1 Mar 2026
Net Income (TTM)
$27.37M
+756.7% YoY Q1 Mar 2026
EPS Diluted (TTM)
$0.75
+722.2% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
16.7%
Q1 Mar 2026
Net Margin
14.3%
Q1 Mar 2026
Free Cash Flow (TTM)
$27.98M
Q1 Mar 2026
Cash
$5.32M
Q1 Mar 2026
Total Debt
$100.68M
Q1 Mar 2026
Shares Outstanding
58.22M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings